FDA official logo
GSRS logo
PFDA official logo

BASILIXIMAB

  • UNII: 9927MT646M
  • Preferred Substance Name: BASILIXIMAB

  • 179045-86-4
  • BASILIXIMAB [EMA EPAR]
  • BASILIXIMAB [INN]
  • BASILIXIMAB [JAN]
  • BASILIXIMAB [MART.]
  • BASILIXIMAB [MI]
  • BASILIXIMAB [PURPLE BOOK, CDER]
  • BASILIXIMAB [USAN]
  • BASILIXIMAB [VANDF]
  • BASILIXIMAB [WHO-DD]
  • CHI-621
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL CHI621 HEAVY CHAIN ANTIHUMAN INTERLEUKIN 2 RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL CHI621 HEAVY CHAIN ANTIHUMAN INTERLEUKIN 2 RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MOUSE MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MOUSE MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
  • SDZ-CHI-621
  • SIMULECT

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.